C. Scher

TET1 and TDG suppress intestinal tumorigenesis by down-regulating the inflammatory and immune response pathways

Yan Zhou, J. Issa, J. Jelinek, 2019, bioRxiv.

Janus Kinase Inhibition in the Aicardi-Goutières Syndrome.

A. Vanderver, J. Shults, H. Dubbs, 2020, The New England journal of medicine.

Treatment of advanced neuroblastoma.

A. Evans, G. D'angio, C. Scher, 1992, European journal of cancer.

Hematologic abnormalities in Aicardi Goutières Syndrome.

A. Vanderver, J. Shults, K. Sullivan, 2022, Molecular genetics and metabolism.

TET1 and TDG suppress inflammatory response in intestinal tumorigenesis: implications for colorectal tumors with the CpG Island Methylator Phenotype.

V. Moreno, J. Issa, J. Jelinek, 2023, Gastroenterology.